Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

机译：具有高疗效疾病改性疗法治疗多发性硬化症的患者Covid-19 mRNA疫苗的体液免疫应答

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The National Multiple Sclerosis Society and other expert organizations recommended that all patients with multiple sclerosis (MS) should be vaccinated against COVID-19. However, the effect of disease-modifying therapies (DMTs) on the efficacy to mount an appropriate immune response is unknown. We aimed to characterize humoral immunity in mRNA-COVID-19 MS vaccinees treated with high-efficacy DMTs.

著录项

期刊名称 Therapeutic Advances in Neurological Disorders
作者
Anat Achiron; Mathilda Mandel; Sapir Dreyer-Alster; Gil Harari; David Magalashvili; Polina Sonis; Mark Dolev; Shay Menascu; Shlomo Flechter; Rina Falb; Michael Gurevich;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类神经科学;
关键词
COVID-19; humoral immune response; mRNA vaccine; multiple sclerosis; SARS-COV-2 IgG;

机译：covid-19;体液免疫应答;mRNA疫苗;多发性硬化;SARS-COV-2 IgG;

相似文献

外文文献
中文文献
专利

1. Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies [J] . Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Therapeutic advances in neurological disorders. . 2021,第a期

机译：作者回复：对具有高疗效疾病修饰治疗的多发性硬化患者对Covid-19 mRNA疫苗的对应对患者的对应性免疫反应
2. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies [J] . Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Therapeutic advances in neurological disorders. . 2021,第a期

机译：具有高效疾病改性治疗的多发性硬化症患者对Covid-19 mRNA疫苗的体液免疫应答
3. Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies [J] . Amanda L. Piquet, John R. Corboy, Timothy L. Vollmer Therapeutic advances in neurological disorders. . 2021,第a期

机译：对应于：高疗效疾病修饰治疗治疗多发性硬化症患者Covid-19 mRNA疫苗的体液免疫应答
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Aging and Disease-modifying Therapies in Multiple Sclerosis: Insights from Clinical Trials and Registries [D] . Zhang, Yinan. 2021

机译：多发性硬化症中的衰老和疾病改性疗法：临床试验和注册管理机构的见解
6. Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies [O] . Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, 2021

机译：作者回复：对具有高疗效疾病修饰治疗的多发性硬化患者对患者对Covid-19 mRNA疫苗的对应对患者的对应性免疫反应
7. Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies [O] . Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, 2021

机译：作者回复：对具有高疗效疾病修饰治疗的多发性硬化患者对患者对Covid-19 mRNA疫苗的对应对患者的对应性免疫反应

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

摘要

著录项

相似文献

相关主题

期刊订阅